Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Other Operating Expenses (2016 - 2023)

Editas Medicine (EDIT) has disclosed Other Operating Expenses for 5 consecutive years, with -$1000.0 as the latest value for Q4 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A to -$1000.0 in Q4 2023 year-over-year; TTM through Sep 2024 was -$1000.0, a 200.0% decrease, with the full-year FY2016 number at $40.5 million, changed N/A from a year prior.
  • Other Operating Expenses was -$1000.0 for Q4 2023 at Editas Medicine, down from $1000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1000.0 in Q3 2019 to a low of -$2000.0 in Q2 2020.
  • A 4-year average of $100.0 and a median of $1000.0 in 2019 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: changed 0.0% in 2020, then tumbled 200.0% in 2021.
  • Editas Medicine's Other Operating Expenses stood at $1000.0 in 2019, then changed by 0.0% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021, then crashed by 200.0% to -$1000.0 in 2023.
  • Per Business Quant, the three most recent readings for EDIT's Other Operating Expenses are -$1000.0 (Q4 2023), $1000.0 (Q2 2023), and $1000.0 (Q4 2021).